VJHemOnc is committed to improving our service to you

SOHO 2020 | ZUMA-1: outcomes of CAR-T in older patients

VJHemOnc is committed to improving our service to you

Sattva S Neelapu

Sattva S Neelapu, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the outcomes of a post-hoc analysis of the ZUMA-1 study (NCT02348216) in older patients (65 years or older). In this subgroup, safety and efficacy were reported to be largely similar compared to the younger patient population, highlighting the promise of CAR T-cell therapies for older patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter